Modern hidradenitis suppurativa (HS) management prioritizes restoration of function and quality of life, not just reduction in lesion counts, according to Barry Resnik, MD.
Barry Resnik, MD
Advertisement
Articles by Barry Resnik, MD
Advertisement
Latest Updated Articles
Raising the Bar for HS Outcomes With Barry Resnik, MDFebruary 8th 2026
Advertisement
Advertisement
Trending on Dermatology Times
1
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
2
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
3
Dermatology Times Spot Test: July 19, 2026
4
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
5